This association between tumor Secretory cDC2 and T cell inflammation suggests that T-cell-attracting chemokines, such as CXCL9, are not only overexpressed by Secretory cDC2 at the transcriptomic level but also at the protein level in cancer. Here, CXCL9 is linked to cancer.